The aim of this study was to evaluate the usefulness of glutamate pyruvate transaminase (GPT) levels in the diagnosis of metabolic syndrome (MS) in obese Japanese children. Methods: We examined 193 obese boys (mean age: 12.1 yrs; mean percent overweight [POW]: 53.9%) and 37 obese girls (mean age: 11.4 yrs; mean POW: 57.2%). Anthropometric measurements, blood pressure and levels of liver transaminases, serum lipids and lipoproteins, fasting blood glucose (FBG), serum insulin and adiponectin were measured. The subjects were divided into either an MS or a non-MS group according to the MS definition criteria for Japanese children.
Introduction
Metabolic syndrome (MS) is a pathological condition that includes a combination of accumulated visceral fat, serum lipid abnormalities, hypertension and impaired glucose tolerance. It is well established that the syndrome is linked closely with cerebral and cardiovascular events and diabetes mellitus in adults and during childhood 1, 2) . The prevalence of MS in children is increasing and diagnostic criteria have been established in Japan 3) , which include waist circumference, children may therefore indicate the presence of insulin resistance and accordingly may be a useful diagnostic marker of MS.
The aim of this study was to clarify the usefulness of serum GPT levels in the diagnosis of MS.
Subjects
We examined 193 obese boys (mean age 12.1 yrs; range 9.6 − 15.4 yrs) and 37 obese girls (mean age 11.4 yrs; range 9.6 − 14.9 yrs) who lived in Niigata Prefecture, Japan and who were receiving regular medical examinations in conjunction with "The Prevention of Cardio-and Cerebrovascular Diseases in Childhood" program. The division of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences and the School Health Division of local governments in Niigata Prefecture undertake this program every year. All subjects were more than 20% overweight based on age-and sex-specified body weight for height (percentage of overweight: POW) and had a body fat percentage 25% for boys or 30% for girls aged 11 years or 35% for girls aged ≥ 11 years. No subjects had known endocrine disorders or diabetes. Anthropometric measurements and blood examinations were performed after informed consent had been obtained from the parents or guardians of all the subjects. The Ethics Committee of the Niigata University Graduate School of Medical and Dental Sciences approved this study.
Methods
Height was measured by a portable stadiometer to the nearest 1 mm and weight by a digital scale to the nearest 0.1 kg. POW was calculated based on the standard body weight of Japanese children published in 1990 by the Ministry of Education, Science and Culture of Japan 11, 12) . Waist and hip circumferences were measured to the nearest 1 mm. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in triplicate in the right arm using an automated sphygmomanometer (Dinamap Model 8104; Critikon Inc., Tampa, USA) with the subjects seated quietly prior to measurements. The third measurement was used in statistical analyses. Body fat percentage was measured by the biological impedance method using a body composition analyzer (RJL Spectrum; RJL Systems, Detroit, USA). Abdominal fat thickness was estimated by ultrasonography (TOSHIBA Model SSA-250A; Toshiba Corp., Tokyo, Japan) 13) . The subjects were placed in the supine position and the linear-array probe kept perpendicular to the skin on the upper medial aspect of the abdomen. A longitudinal scan was then performed from the xyphoid process to the navel along the linea alba. Scanning was performed in the optimal position, with the surface of the liver being kept almost parallel to the skin by requesting that the subjects hold their breath. The probe was applied lightly to the skin in order to avoid compression of the fat layer. Maximum preperitoneal fat thickness (Pmax) was measured directly from the screen using electronic calipers 14) . We also evaluated whether the liver had a hyperechoic texture, indicating diffuse fatty infiltration.
Blood samples were collected from the subjects after an overnight fast for measurement of serum liver enzymes, lipid levels, lipoproteins, fasting blood glucose (FBG), fasting serum insulin and adiponectin. The homeostasis model assessment-insulin resistance (HOMA-R) was also calculated.
Statistical Analysis
The subjects were divided into two groups, those with MS (MS group) and those without MS (non-MS group). Although criteria for defining MS in adults have been published by the World Health Organization 4) and the National Cholesterol Education Program Adult Treatment 5) , there is no consensus concerning the criteria for children. We therefore used the provisional criteria for Japanese children proposed by the study group of the Ministry of Health, Labor and Welfare of Japan 3) . These criteria include: 1) waist circumference ≥ 80 cm for middle school-aged children and ≥ 75cm for elementary-aged children; 2) serum triglyceride (TG) levels ≥ 120 mg/dL or high-density lipoprotein (HDL) cholesterol levels 40 mg/dL; 3) FBG levels ≥ 100 mg/dL; 4) SBP ≥ 125 mmHg or DBP ≥ 70 mmHg. A diagnosis of MS was made in children who complied with 1) and had at least two of the other criteria 2) to 4).
In addition, both boys and girls were divided into four groups according to the number of corresponding MS criteria. The number of MS criteria ranged from the MSB0 group (0) to the MSB3 group (3) in boys, and from the MSG0 group (0) to the MSG3 group (3) in girls. No subject of either gender had all four criteria of MS and therefore the MSB3 and MSG3 groups equate to the MS group in boys and girls, respectively.
Age, height, weight, SBP, DBP and FBG were normally distributed and are expressed as range, median, mean and SD. All other parameters were not normally distributed and were expressed as range, median and mean. Age, height and weight were ana-lyzed using unpaired t -tests, while the other parameters were analyzed using the Mann-Whitney U test. The relationships between waist circumference, SBP, DBP, Pmax, metabolism-related laboratory data, HOMA-R and GPT were examined using Spearman's rank-correlation coefficients.
Parametric one-way analysis of variance (ANOVA) was used to examine differences in metabolism-related data between groups MSB0-MSB3 and MSG0-MSG3. All data were log-transformed before analysis and the results expressed as the mean SD for both original and log-transformed values. Post hoc comparisons between pairs of means were carried out using Scheffe's test.
Receiver operating characteristic (ROC) curves were drawn and the area under the curve (AUC) calculated in order to compare the effectiveness of metabolism-related markers, including GPT, TG, HDL, FBG, serum insulin and adiponectin to detect MS in boys. We analyzed the data of the 101 boys in the study group who had adiponectin levels measured. Data of the girls were not analyzed due to the small number of adiponectin assays. HDL and adiponectin levels were multiplied by -1 as they are inversely related to the MS risk.
All statistical analyses were carried out using Dr SPSS for Windows Ver.11.0.1 J (SPSS Inc., Chicago, USA). Probability (p) values 0.05 were considered significant in all analyses. Table 1 shows the clinical characteristics of the subjects. All anthropometric measurements and metabolism-related laboratory data were grouped according to gender. Table 2 , 3 show the anthropometric measurements and metabolism-related laboratory data of the subjects, classified as either MS (97 boys and 19 girls) or non-MS (96 boys and 18 girls), respectively. There were no significant differences in age between the two groups, whereas anthropometric measurements and laboratory data, excluding body fat percentage and HDL, were significantly higher in the MS group in both genders. 
Results

Clinical Characteristics of the Subjects
Comparison of the MS and Non-MS Groups
Correlations between Anthropometric Measurements, Metabolism-Related Laboratory Data and GPT
The relationships between GPT and waist circumference, SBP, DBP, Pmax, metabolism-related laboratory data, HOMA-R are shown in Table 4 . Waist circumference correlated positively with GPT in both boys and girls. Similarly, blood pressure, especially SBP, showed positive correlations with GPT in both genders. Pmax showed the same relationships as waist circumference and blood pressure. In the metabolismrelated laboratory data, TG and serum insulin were correlated positively with GPT, whereas FBG was not correlated with GPT in either gender. T-chol, HDL and LDL showed weak correlations with GPT in boys, while T-chol and LDL were positively correlated with GPT in girls. Of these metabolism-related parameters, serum insulin showed the strongest correlation with GPT in both genders. HOMA-R exhibited virtually the same relationships as serum insulin in both genders, while SBP showed similar results in girls only.
Metabolism-Related Laboratory Data of the Subjects Divided into Four Groups According to the Number of MS Components
The data summarized in Table 5 , 6 confirm the relationships between metabolism-related laboratory data and the corresponding number of MS criteria in boys and girls. There were no significant differences in FBG between the MS (MSB3 and MSG3) groups and non-MS groups, whereas GPT, TG, HDL and serum insulin levels were significantly different between the MSB3, MSG3 and other groups.
ROC Comparing the Effectiveness of Metabolism-Related Markers as Markers for Detecting MS in Boys
The ROC curves showed that values of serum insulin and TG were excellent markers for detecting MS with the AUC and 95% confidence interval (95%CI) being 0.929 (0.879 − 0.978) and 0.859 (0.784 − 0.933), respectively. Although the AUC for GPT, HDL and adiponectin had marginally lower values [0.743 (0.649 − 0.838), 0.731 (0.635 − 0.828) and 0.714 (0.611 − 0.817), respectively], these values were markedly higher than the value for FBG [0.510 (0.395 − 0.625)]. We showed AUC and 95%CI of all these parameters in Fig. 1 , although only serum insulin, TG and GPT are expressed in graph form to ensure the readability of the graph.
We consider that 40 IU/L is an appropriate cutoff point of GPT for diagnosing MS in boys (sensitivity: 58%, specificity: 81%). The cutoff value for girls was not calculated due to the small sample size.
Ultrasonography of the liver exhibited high echo intensity in 73 of 74 boys and all 11 girls with GPT levels above 40 IU/L.
Discussion
In the majority of cases, NAFLD is asymptomatic and therefore diagnosis is usually made noninvasively by the detection of elevated serum GPT levels.
This increase in GPT levels also occurs with other chronic liver diseases, such as alcoholic hepatitis, druginduced liver dysfunction, autoimmune hepatitis and chronic viral hepatitis; however, as these diseases are all relatively rare in childhood, elevated serum GPT levels in obese children have a high probability of indicating NAFLD. In our study, ultrasonography of the liver showed a hyperechoic texture in almost all children with elevated GPT levels, indicating fat accumulation in liver cells. Although the etiology of NAFLD is still not fully understood, it is thought that fat accumulation in liver cells caused by insulin resistance is an important trigger in the disease process [8] [9] [10] . This indicates that elevation of serum GPT levels in obese children is most likely caused by insulin resistance. As insulin resistance is one of the essential characteristics of MS, elevated GPT levels may therefore indicate increased the risk of MS in childhood.
Our results revealed that metabolism-related parameters, including GPT, were all higher in both boys and girls with MS. Furthermore, of the parameters which are criteria for MS, Pmax, serum insulin levels, HOMA-R, GPT correlated positively only with serum insulin levels and HOMA-R in both boys and girls. The degree of correlation of these two parameters was similar in both genders, indicating that serum insulin levels strongly reflect insulin resistance, whereas abnormal FBG may be difficult to detect in children 15) . These findings indicated that elevated GPT levels were related with MS through insulin resistance.
Our results revealed significant differences in TG, HDL, GPT and serum insulin levels between MS groups (MSB3 in boys and MSG3 in girls) and non-MS groups (MSB0 − MSB2 in boys and MSG0 − MSG2 in girls). In contrast, FBG levels were not different between these groups, a finding indicating that GPT and serum insulin are superior to FBG as criteria for defining MS.
Evaluation of the ROC curves showed that serum insulin and TG were superior markers of MS, followed in ranking order by GPT, HDL and adiponectin. ROC curves demonstrated that FBG was less useful as a marker of MS than other parameters. As serum insulin levels reflect insulin resistance in non-diabetic conditions, it follows that adiponectin levels also correspond to the degree of insulin resistance. It is well established that serum adiponectin levels are decreased in insulin-resistant conditions 16, 17) . This finding, combined with our results, shows that adiponectin has important roles in the pathogenesis of MS. Our data show that, in comparison with adiponectin, GPT has a similar value as a marker of MS. In addition, GPT can be measured easily and is not influenced by the timing of blood sampling that affects tests such as TG and FBG.
At this time, it remains unclear whether the presence of MS in childhood increases the risk of coronary or cerebrovascular disease in adulthood. The relationship between visceral fat accumulation and increased risk of cardiovascular disease has however also been reported in childhood 18) and it is therefore conceivable that MS in childhood will become a serious public health problem in the near future. Accordingly, the increased prevalence of MS in children warrants close attention. There is therefore a need for the earliest possible diagnosis of MS in order to initiate aggressive medical intervention and to avoid the development of subsequent life-threatening events.
In conclusion, our study showed that GPT was superior to FBG as a marker for defining MS, as it appeared to closely reflect the level of insulin resistance. 
